OMICS Group, the World class Open access Publisher and Scientific event Organizer is hosting “International Conference and Exhibition on Molecular Medicine and Diagnostics” during August 24-26, 2015 at London, UK. The conference highlights the theme “Exploring the current techniques and research in the field of Molecular medicine and Diagnostics”. The conference discusses the latest research outcomes and technological advancements in the field and brings together leading physicians, research scholars, students along with industrial and pharma professionals to exchange share their views on critical aspects of Molecular medicine research. The event is designed in a way to provide an exclusive platform for new researchers, scholars and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Molecular medicine. Molecular medicine-2015 conference will comprise leading keynote speakers, session speakers, poster presenters who will be presenting their research on the topics Molecular Medicine and Personalized Healthcare, Current advances and Clinical aspect of Molecular Medicine, Molecular Diagnostic, genetics medicine, Molecular Biomarkers, Evolution of Molecular Genomics, Internal molecular medicine, Cancer Immunology and Oncology, Cell and Gene Therapy, Advanced Gene Therapeutics, and Clinical trials and Research in Cell and Genetic sciences.        

OMICS International organizes 300+ International Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and publishes 500+ Open Access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. 

The main topic of interest of the best academic conference, Molecular Medicine will provide the latest novel applications in molecular mechanisms and therapeutic developments. It will also offer new ideas and approaches for research and offer the opportunity for scientists to collaborate with the experts in this field. Our panel of distinguished speakers will present their recent discoveries and most updated scientific information, which will make for a very exciting and rewarding conference to attend. Molecular medicine strives to promote the understanding of normal body functioning and disease pathogenesis at the molecular level, and to allow researchers and physician-scientists to use that knowledge in the design of specific tools for disease diagnosis, treatment, prognosis, and prevention.

                       Scientific Session

Track 1: Molecular medicine and Personalized Healthcare

Molecular medicine (the applications of DNA knowledge to medical practice) has moved into the genomics era with the promise that personalized medical care will now be greatly enhanced, including the options for more effective prevention and the development of new therapies targeted to molecular defects. At the same time, the traditional health professional-patient interaction is being challenged by the growth of Internet-based direct-to-consumer DNA testing and counseling. The increasing internationalization of genomic research has led to the development of more effective approaches to studying complex multifactorial genetic disorders, while at the same time highlighting new challenges in ethical, legal and social issues. In this complex environment, students and a wide range of health professionals need to keep abreast of new developments (often driven by the public, media or the Internet) while not necessarily having the opportunity or time to understand the basics.

Personalized healthcare refers specifically to the use of genetics and genomics. An example of personalized medicine includes the use of specific tumor markers to guide therapy for breast cancer. We view personalized healthcare as a broader platform that includes genetics and genomics but also includes any other biologic information that helps predict risk for disease or how a patient will respond to treatments. A genetic disorder is a genetic problem caused by one or more abnormalities in the genome, especially a condition that is present from birth (congenital). Most genetic disorders are quite rare and affect one person in every several thousands or millions. Molecular and Cellular Therapies is the cellular modifications at the molecular level. Take the chemotherapy in oncology for example, it aims to kill the cell by delivering toxic agents to the cell, while Molecular therapies could aim to terminate the cellular division without necessarily killing the cell, such as aiming to reach senescence whose therapeutic procedure, levels of toxic agents, and tools for delivering the toxicity could all be very different from simply killing the cell. Internal medicine is the medical specialty dealing with the prevention, diagnosis, and treatment of adult diseases. Physicians specializing in internal medicine are called internists or physicians (without a modifier) in Commonwealth nations. Internists are skilled in the management of patients who have undifferentiated or multi-system disease processes. Internists care for hospitalized and ambulatory patients and may play a major role in teaching and research.

Track 2: Current advances and Clinical aspect of Molecular Medicine

 Epigenomics is still a growing field and young in comparison to its counterparts. Investigators are facing many challenges in terms of immunotherapeutic research and instrumental analysis. This conference is for the scientists, researchers, laboratory leaders, and managers who are working in the field and allows these experts to share their findings and techniques in order to bridge technological and computational gaps that affect datasets, interpretation, and the clinical applications of epigenomics. Centre for Molecular Medicine research in Europe (CeMM) is a young, international, independent and interdisciplinary Research Center in Molecular Medicine, situated on the campus of the Medical University and the General Hospital in the heart of Vienna. “From the clinic to the clinic”: driven by medical needs, CeMM integrates basic research and clinical expertise to pursue innovative diagnostic and therapeutic approaches. The work of 13 research groups with about 150 scientists focuses on cancer, inflammation and immune disorders. The goal of CeMM is to assist in preparing the predictive, preventive and personalized medicine of the future, and to be training and teaching center for a new generation of researchers in molecular medicine. According to a survey from “The Scientist” CeMM is ranked as the best European place to work in Academia 2012.

Molecular gene is the field of biology and genetics that studies the structure and function of genes at a molecular level. Molecular genetics employs the methods of genetics and molecular biology to elucidate molecular function and interactions among genes. It is so called to differentiate it from other sub fields of genetics such as ecological genetics and population genetics.

Track 3: Advanced Molecular Diagnostics

Molecular diagnostics is a technique used to analyses biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. The technique is used to diagnose and monitor disease, detect risk, and decide which therapies will work best for individual patients.  By analyzing the specifics of the patient and their disease, molecular diagnostics offers the prospect of personalized medicine. Blotting Techniques - Blotting is the technique in which nucleic acids or proteins are immobilized onto a solid support generally nylon or nitrocellulose membranes. Blotting of nucleic acid is the central technique for hybridization studies. Nucleic acid labeling and hybridization on membranes have formed the basis for a range of experimental techniques involving understanding of gene expression, organization, etc. The global molecular diagnostics market will reach $7,956.9 million by 2018, growing at a CAGR of 9.7% during the forecast period (2013–2018).

The global molecular diagnostics market is segmented on the basis of application, technology, end user, product, and geography. Based on application, the market is further segmented into infectious diseases, oncology, genetics, blood screening, microbiology, and others. Infectious diseases secured the largest market share, whereas oncology was the fastest growing segment amongst the rest. The driving forces of the molecular diagnostics market include the rising incidences of infectious diseases, genetic disorders, cancer, and technological developments like portability of equipment.

Track 4: Molecular Biomarkers

Molecular Biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism. DNA marker is a term used to refer to a specific DNA variation between individuals that has been found to be associated with a certain characteristic (e.g., increased tenderness). These different DNA or genetic variants are known as alleles.  A genetic marker is a gene or DNA sequence with a known location on a chromosome that can be used to identify individuals or species. It can be described as a variation (which may arise due to mutation or alteration in the genomic loci) that can be observed. A genetic marker may be a short DNA sequence, such as a sequence surrounding a single base-pair change (single nucleotide polymorphism, SNP), or a long one, like minisatellites.

A DNA microarray (also commonly known as DNA chip or biochip) is a collection of microscopic DNA spots attached to a solid surface. Scientists use DNA microarrays to measure the expression levels of large numbers of genes simultaneously or to genotype multiple regions of a genome.

Track 5: Evolution of Molecular Genomics

Molecular evolution is a change in the sequence composition of cellular molecules such as DNA, RNA, and proteins across generations. The field of molecular evolution uses principles of evolutionary biology and population genetics to explain patterns in these changes. Major topics in molecular evolution concern the rates and impacts of single nucleotide changes, neutral evolution vs. natural selection, origins of new genes, the genetic nature of complex traits, the genetic basis of speciation, evolution of development, and ways that evolutionary forces influence genomic and phenotypic changes. DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. It includes any method or technology that is used to determine the order of the four bases—adenine, guanine, cytosine, and thymine—in a strand of DNA. The advent of rapid DNA sequencing methods has greatly accelerated biological and medical research and discovery. Metagenomics is the study of genetic material recovered directly from environmental samples. The broad field may also be referred to as environmental genomics, ecogenomics or community genomics.

Track 6: Cancer Immunology and Oncology

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells. It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, is of particular interest in the field as knowledge gained drives the development of targeted therapy and tumor marker-based diagnostic tests. One of the hottest ideas in science is that you can stimulate the immune system to fight cancer. There has been such a surge in pharmaceutical R&D in this field that someone has come up with a single place for investors interested in cancer immunotherapy stocks.

 The Cancer Immunotherapy Market will increase to nearly $9 Billion across the World’s major Pharmaceutical Markets in 2022. The immunotherapy market will experience considerable growth through 2022, increasing from $1.1 billion in 2012 to nearly $9 billion in 2022 (corresponding to 23.8 percent annual growth) in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.

Track 7: Cell and Gene Therapy

Cell therapy (also called cellular therapy or cytotherapy) is therapy in which cellular material is injected into a patient; this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy. Molecular Therapy is the cellular modifications at the molecular level. Take the chemotherapy in oncology for example, it aims to kill the cell by delivering toxic agents to the cell, while Molecular therapies could aim to terminate the cellular division without necessarily killing the cell, such as aiming to reach senescence whose therapeutic procedure, levels of toxic agents, and tools for delivering the toxicity could all be very different from simply killing the cell. Cardiovascular Cell Therapy Research Network (CCTRN) is a network of physicians, scientists, and support staff dedicated to studying stem cell therapy for treating heart disease. The CCTRN is funded by the National Institutes of Health (NIH) and includes expert researchers with experience in cardiovascular care at five stem cell centers in the United States. The goals of the Network are to complete research studies that will potentially lead to more effective treatments for patients with cardiovascular disease, and to share knowledge quickly with the healthcare community. Genetic Screening is an analysis of DNA samples to detect the presence of a gene or genes associated with an inherited disorder. RNA Therapeutics Market is expected to reach $1.2 Billion, Globally, by 2020 - Allied Market Research.

Track 8: Advanced Gene Therapeutics

Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease. The polymers are either expressed as proteins, interfere with protein expression, or possibly correct genetic mutations. Gene therapy utilizes the delivery of DNA into cells, which can be accomplished by several methods. The two major classes of methods are those that use recombinant viruses (sometimes called biological nanoparticles or viral vectors) and those that use naked DNA or DNA complexes (non-viral methods).

The most common form uses DNA that encodes a functional, therapeutic gene to replace a mutated gene. The polymer molecule is packaged within a "vector", which carries the molecule inside cells. Gene therapy was conceptualized in 1972, by authors who urged caution before commencing human gene therapy studies. The first gene therapy experiment approved by the US Food and Drug Administration (FDA) occurred in 1990, when Ashanti DeSilva was treated for ADA-SCID. By January 2014, some 2,000 clinical trials had been conducted or approved.

Tumor suppressor gene is a gene that protects a cell from one step on the path to cancer. When this gene mutates to cause a loss or reduction in its function, the cell can progress to cancer, usually in combination with other genetic changes. Systems medicine is an interdisciplinary field of study that looks at the systems of the human body as part of an integrated whole, incorporating biochemical, physiological, and environment interactions. Systems medicine draws on systems science and systems biology, and considers complex interactions within the human body in light of a patient's genomics, behavior and environment.

International Conference and Exhibition on Molecular Medicine and Diagnostics 2015

                                                                                                                               Aug 24-26, 2015

                                                                      Market Analysis

Summary of Molecular Medicine Conference

Molecular Medicine-2015 welcomes attendees, presenters, and exhibitors from all over the world to London, UK. We are delighted to invite you all to attend and register for the “International Conference & Exhibition on Molecular Medicine & Diagnostics” (Molecular Medicine workshops) which is going to be held during August 24-26, 2015 in London, UK. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops, poster presentations on diverse topics, and business meetings interconnecting people all over the globe. We invite you to join us at the Molecular Medicine-2015 (systems medicine conferences), where you will be sure to have a meaningful experience with scholars around the world. We look forward to meeting you in London, UK.

For more details please visit: http://molecularmedicine.conferenceseries.com/

Conference Highlights

• Molecular Medicine and Personalized Healthcare
• Current advances and Clinical aspect of Molecular Medicine
• Molecular Diagnostics
• Molecular Biomarkers
• Evolution of Molecular Genomics
• Cancer Immunology and Oncology
• Cell and Gene Therapy
• Advanced Gene Therapeutics
• Clinical Trials and Research in Cell and Genetic sciences

Scope & Importance

Molecular Medicine conferences mostly comprises of the topics like Genetics, Bioinformatics, and Bio-Engineering etc. which are certainly a key issue in the modern perspective and through this conference we will get all relevant information. Conference is the quite essential platform for sharing vivid knowledge. This will provide scientific advancements in their respective field. Though the internet surely provides a true platform to know about international researches, but understanding the research from the inventor has no replacement. International conferences provide that perfect platform. Conference on Molecular Medicine is a much celebrated conference which basically deals with the latest research and developments in the sphere of biological science. Molecular Medicine meetings will provide a perfect stage to all the Researchers, Students to present their Research work on the respective sphere by interacting with highly eminent personal like Professors, Doctors & Scientists etc. Thus, they will get more ideas & Suggestion.

Why London (UK)?

The United Kingdom of Great Britain and Northern Ireland, commonly known as the United Kingdom (United Kingdom) or Britain is a sovereign state located off the north-western coast of continental Europe. The country includes the island of Great Britain (a term sometimes loosely applied to the whole state), the north-eastern part of the island of Ireland, and many smaller islands. The total area of the United Kingdom is approximately 243,610 square kilometers (94,060 sq mi). The country occupies the major part of the British Isles archipelago and includes the island of Great Britain, the north-eastern one-sixth of the island of Ireland and some smaller surrounding islands. The United Kingdom has a temperate climate, with plentiful rainfall all year round. England and Scotland was leading Centre of the Scientific Revolution from the 17th century and the United Kingdom led the Industrial Revolution from the 18th century, and has continued to produce scientists and engineers credited with important advances. Scientific research and development remains important in British universities, with many establishing science parks to facilitate production and co-operation with industry. Between 2004 and 2008 the United Kingdom produced 7% of the world’s scientific research papers and had an 8% share of scientific citations, the third and second highest in the world.

Topics to be mainly focused

• University contacts
• Associations Involvement for collaborations
• Companies related to conference theme
• Encouraging active student participations in groups
• Qualitative indexing and press releases
• Through promotions in social network sites
• Blog posts
• Advertisements/attending in competitive conferences for mutual promotions
• Exhibitors/sponsors

Why to Attend?

Meet your target Scientists, Professors and students with members from around the world focused on learning about Molecular Medicine; this is your single best opportunity to reach the largest assemblage of participants from all over the world. Conduct demonstrations, distribute information, meet with current and potential scientific discoveries, make a splash with a new product line, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Molecular Medicine fields are hallmarks of this conference.

Members Associated with Molecular Medicine Research

Hospitals Associated with Molecular Medicine Research

There are about 680 hospitals hospital and research Centre related to Molecular Medicine worldwide and 76 of them are London, UK.

London, UK                                                                                       Globe

London Guy's Hospital Genetic Centre                  Bristol Genetics Laboratory

St Thomas’ Hospital                                            East Anglian Medical Genetics Service

Evelina London                                                    Manchester Centre for Genomic

Societies Associated with Molecular Medicine Research

To encourage, educate, update and train registered medical practitioners, geneticists, qualified nurses and other appropriately qualified paramedical personnel in the field of Molecular Medicine Research various well-known societies/associations are working across the globe to efficiently prevent and combat the fatal disease.

Major Molecular Medicine Research Societies around the Globe

• British Society and Gene and Cell Therapy
• American Society of Gene and Cell Therapy (ASGCT)
• Australasian Gene Therapy Society (AGTS)
• Austrian Network for Gene Therapy
• British Society of Gene Therapy (BSGT)
• European Society of Gene and Cell Therapy (ESGCT)
• Finnish Gene Therapy Society (FGTS)
• German Gene Therapy Society (DGGT)
• International Society for Cancer Gene Therapy (ISCGT)
• Irish Society for Gene & Cell Therapy (ISGCT)
• Israeli Society of Gene & Cell Therapy (ISGCT)
• Japan Society of Gene Therapy (JSGT)
• Korean Society of Gene and Cell Therapy (KSGCT)
• Netherlands Society of Gene and Cell Therapy (NVGCT)
• Spanish Society of Gene and Cell Therapy (SETGyC)
• Swedish Society for Gene and Cell Therapy (SSGCT)
• Turkish Society of Gene & Cell Therapy (TSGCT)

Companies Associated with Molecular Medicine Research

Here are some of the companies associated with Molecular Medicine Research:

• Affymetrix, UK
• Amgen, US
• Applera, Norwalk, CT
• Applied Biosystems, Foster City, CA
• Asper Biotech
• Celera Genomics
• DeCODE genetics, IS
• Genetix, Hampshire, UK
• GenePeeks, NY
• LGC Genomics, UK

Universities Associated with Molecular Medicine Research

Here is the list for some of the top Universities related with Molecular Medicine in London, UK and worldwide.

• Harvard University, USA
• Massachusetts Institute of Technology
• University of California--San Francisco
• University of Cambridge
• Stanford University
• University of Oxford
• Johns Hopkins University
• University of California--San Diego
• University of Washington
• Yale University
• University of Toronto
• University of Pennsylvania, USA
• Imperial College London
• Columbia University
• University of Chicago
• Duke University

Market Value on Molecular Medicine Research

The global Molecular Medicine market in UK is $ 4.8 billion where as it is $ 11 billion in USA. The market value for Molecular Medicine research in 2015 throughout the world is $24 billion.

Market Growth of Molecular Medicine Research in the last and upcoming ten years

Medical doctors, patients and health care providers consider the prevention of genetic diseases as an essential tool to improve the general health status of the population and the proportion of people suffering from genetics and genomics disease will increase by 65.2% by 2025. The top institutions researching in the related studies have been funded with 100 Billion Dollar worldwide. According to recent statistics genetic diseases worldwide will double between 2012 and 2025. The current market value of Molecular Medicine is $24 billion and is expected to reach more than $100 billion by 2025.

Fund alloted to Molecular Medicine & Genetics

Statistics of Physicians, Researchers and Academicians working on Molecular Medicine

Molecular Medicine conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates, Doctors, and talented student communities in the field of medicine under a single roof where networking and global partnering happens for the acceleration of future research. Following are the statistics percentage wise: